These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 455093)

  • 1. Localization of dopamine receptors in rat brain.
    Reisine TD; Nagy JI; Fibiger HC; Yamamura HI
    Brain Res; 1979 Jun; 169(1):209-14. PubMed ID: 455093
    [No Abstract]   [Full Text] [Related]  

  • 2. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine and opiate receptors: localization in the striatum and evidence for their axoplasmic transport in the nigrostriatal and striatonigral pathways.
    Van der Kooy D; Weinreich P; Nagy JI
    Neuroscience; 1986 Sep; 19(1):139-46. PubMed ID: 2431346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
    Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
    Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The localization of receptor binding sites in the substantia nigra and striatum of the rat.
    Reisine TD; Nagy JI; Beaumont K; Fibiger HC; Yamamura HI
    Brain Res; 1979 Nov; 177(2):241-52. PubMed ID: 227532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
    Quik M; Emson PC; Joyce E
    Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in guanine nucleotide sensitive and insensitive 3H-ADTN binding in striatum following substantia nigra lesions.
    Hirschhorn ID; Makman MH; Gardner EL
    Eur J Pharmacol; 1980 Mar; 62(1):123-4. PubMed ID: 6154585
    [No Abstract]   [Full Text] [Related]  

  • 8. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine agonist potencies of ergolines.
    Lew JY; Nakamura S; Battista AF; Goldstein M
    Commun Psychopharmacol; 1979; 3(3):179-83. PubMed ID: 115634
    [No Abstract]   [Full Text] [Related]  

  • 10. The effects of nigrostriatal 6-hydroxydopamine lesions on dopamine D2 receptor mRNA and opioid systems.
    Mansour A; Meador-Woodruff JH; Camp DM; Robinson TE; Bunzow J; Van Tol H; Civelli O; Akil H; Watson SJ
    Prog Clin Biol Res; 1990; 328():227-30. PubMed ID: 2106148
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function.
    Kelly PH; Moore KE
    Nature; 1976 Oct; 263(5579):695-6. PubMed ID: 980114
    [No Abstract]   [Full Text] [Related]  

  • 12. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.
    Björklund A; Stenevi U
    Brain Res; 1979 Nov; 177(3):555-60. PubMed ID: 574053
    [No Abstract]   [Full Text] [Related]  

  • 13. Histofluorescence of kainic acid-induced striatal lesions.
    Meibach RC; Brown L; Brooks FH
    Brain Res; 1978 Jun; 148(1):219-23. PubMed ID: 656926
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of kainic acid on striatal dopamine receptors.
    Weinreich P; Seeman P
    Brain Res; 1980 Oct; 198(2):491-6. PubMed ID: 7407614
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dopamine agonists in the therapy of parkinson syndrome].
    Kapfhammer HP; Rüther E
    Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
    [No Abstract]   [Full Text] [Related]  

  • 16. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 17. Binding of [3H]apomorphine to striatal membranes prepared from rat brain after 6-hydroxydopamine and kainic acid lesions.
    Fujita N; Saito K; Iwatsubo K; Hirata A; Noguchi Y; Yoshida H
    Brain Res; 1980 May; 190(2):593-6. PubMed ID: 7370810
    [No Abstract]   [Full Text] [Related]  

  • 18. Unitary dopaminergic receptor composed of cooperatively linked agonist and antagonist sub-unit binding sites.
    Leysen JE
    Commun Psychopharmacol; 1979; 3(6):397-410. PubMed ID: 546588
    [No Abstract]   [Full Text] [Related]  

  • 19. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
    Creese I; Snyder SH
    Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supersensitivity of the cholinergic response to apomorphine in the striatum following denervation or disuse supersensitivity of dopaminergic receptors in the rat.
    Consolo S; Ladinsky H; Samanin R; Bianchi S; Ghezzi D
    Brain Res; 1978 Oct; 155(1):45-54. PubMed ID: 210895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.